$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2018-05-10 AccNo: 0001193125-18-158323 Size: 16 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接